Selected research
Market Structure
Global Artemisinin Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Artemisinin Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Artemisinin Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Artemisinin Derivatives include Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Shanghai Natural Bio-engineering, Sanofi, Kunming Pharmaceutical, Kerui Nanhai, Guilin Pharmaceutical, Guangxi Xiancaotang Pharmaceutical and Guangxi Xiancaotang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Artemisinin Derivatives output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Artemisinin Derivatives by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Artemisinin Derivatives market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artemisinin Derivatives and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artemisinin Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemisinin Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.
Artemisinin Derivatives Segment by Company
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Shanghai Natural Bio-engineering
Sanofi
Kunming Pharmaceutical
Kerui Nanhai
Guilin Pharmaceutical
Guangxi Xiancaotang Pharmaceutical
Guangxi Xiancaotang
Novanat Bioresource
KPC Pharmaceuticals
Botanical Extracts EPZ Ltd
ArtemiFlow
Artemisinin Derivatives Segment by Type
Dihydroartemisinin
Artemisunate
Others
Artemisinin Derivatives Segment by Application
Malaria Treatment
Scientific Research
Others
Artemisinin Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemisinin Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artemisinin Derivatives market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemisinin Derivatives industry.
Chapter 3: Detailed analysis of Artemisinin Derivatives market competition landscape. Including Artemisinin Derivatives manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Artemisinin Derivatives by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Artemisinin Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dihydroartemisinin
- Artemisunate
- Others
Applications
- Malaria Treatment
- Scientific Research
- Others
Companies covered
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Shanghai Natural Bio-engineering
- Sanofi
- Kunming Pharmaceutical
- Kerui Nanhai
- Guilin Pharmaceutical
- Guangxi Xiancaotang Pharmaceutical
- Guangxi Xiancaotang
- Novanat Bioresource
- KPC Pharmaceuticals
- Botanical Extracts EPZ Ltd
- ArtemiFlow
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Artemisinin Derivatives Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Artemisinin Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Artemisinin Derivatives Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Artemisinin Derivatives Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Artemisinin Derivatives Market Dynamics
- 2.1 Artemisinin Derivatives Industry Trends
- 2.2 Artemisinin Derivatives Industry Drivers
- 2.3 Artemisinin Derivatives Industry Opportunities and Challenges
- 2.4 Artemisinin Derivatives Industry Restraints
3 Artemisinin Derivatives Market by Manufacturers
- 3.1 Global Artemisinin Derivatives Production Value by Manufacturers (2021-2026)
- 3.2 Global Artemisinin Derivatives Production by Manufacturers (2021-2026)
- 3.3 Global Artemisinin Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Artemisinin Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemisinin Derivatives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artemisinin Derivatives Manufacturers, Product Type & Application
- 3.7 Global Artemisinin Derivatives Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artemisinin Derivatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artemisinin Derivatives Players Market Share by Production Value in 2025
- 3.8.3 2025 Artemisinin Derivatives Tier 1, Tier 2, and Tier 3
4 Artemisinin Derivatives Market by Type
- 4.1 Artemisinin Derivatives Type Introduction
- 4.1.1 Dihydroartemisinin
- 4.1.2 Artemisunate
- 4.1.3 Others
- 4.2 Global Artemisinin Derivatives Production by Type
- 4.2.1 Global Artemisinin Derivatives Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artemisinin Derivatives Production by Type (2021-2032)
- 4.2.3 Global Artemisinin Derivatives Production Market Share by Type (2021-2032)
- 4.3 Global Artemisinin Derivatives Production Value by Type
- 4.3.1 Global Artemisinin Derivatives Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artemisinin Derivatives Production Value by Type (2021-2032)
- 4.3.3 Global Artemisinin Derivatives Production Value Market Share by Type (2021-2032)
5 Artemisinin Derivatives Market by Application
- 5.1 Artemisinin Derivatives Application Introduction
- 5.1.1 Malaria Treatment
- 5.1.2 Scientific Research
- 5.1.3 Others
- 5.2 Global Artemisinin Derivatives Production by Application
- 5.2.1 Global Artemisinin Derivatives Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artemisinin Derivatives Production by Application (2021-2032)
- 5.2.3 Global Artemisinin Derivatives Production Market Share by Application (2021-2032)
- 5.3 Global Artemisinin Derivatives Production Value by Application
- 5.3.1 Global Artemisinin Derivatives Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artemisinin Derivatives Production Value by Application (2021-2032)
- 5.3.3 Global Artemisinin Derivatives Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Kerui Nanhai Pharmaceutical
- 6.1.1 Kerui Nanhai Pharmaceutical Company Information
- 6.1.2 Kerui Nanhai Pharmaceutical Business Overview
- 6.1.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.1.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Portfolio
- 6.1.5 Kerui Nanhai Pharmaceutical Recent Developments
- 6.2 Shanghai Natural Bio-engineering Co
- 6.2.1 Shanghai Natural Bio-engineering Co Company Information
- 6.2.2 Shanghai Natural Bio-engineering Co Business Overview
- 6.2.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.2.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Portfolio
- 6.2.5 Shanghai Natural Bio-engineering Co Recent Developments
- 6.3 Shanghai Natural Bio-engineering
- 6.3.1 Shanghai Natural Bio-engineering Company Information
- 6.3.2 Shanghai Natural Bio-engineering Business Overview
- 6.3.3 Shanghai Natural Bio-engineering Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.3.4 Shanghai Natural Bio-engineering Artemisinin Derivatives Product Portfolio
- 6.3.5 Shanghai Natural Bio-engineering Recent Developments
- 6.4 Sanofi
- 6.4.1 Sanofi Company Information
- 6.4.2 Sanofi Business Overview
- 6.4.3 Sanofi Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.4.4 Sanofi Artemisinin Derivatives Product Portfolio
- 6.4.5 Sanofi Recent Developments
- 6.5 Kunming Pharmaceutical
- 6.5.1 Kunming Pharmaceutical Company Information
- 6.5.2 Kunming Pharmaceutical Business Overview
- 6.5.3 Kunming Pharmaceutical Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.5.4 Kunming Pharmaceutical Artemisinin Derivatives Product Portfolio
- 6.5.5 Kunming Pharmaceutical Recent Developments
- 6.6 Kerui Nanhai
- 6.6.1 Kerui Nanhai Company Information
- 6.6.2 Kerui Nanhai Business Overview
- 6.6.3 Kerui Nanhai Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.6.4 Kerui Nanhai Artemisinin Derivatives Product Portfolio
- 6.6.5 Kerui Nanhai Recent Developments
- 6.7 Guilin Pharmaceutical
- 6.7.1 Guilin Pharmaceutical Company Information
- 6.7.2 Guilin Pharmaceutical Business Overview
- 6.7.3 Guilin Pharmaceutical Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.7.4 Guilin Pharmaceutical Artemisinin Derivatives Product Portfolio
- 6.7.5 Guilin Pharmaceutical Recent Developments
- 6.8 Guangxi Xiancaotang Pharmaceutical
- 6.8.1 Guangxi Xiancaotang Pharmaceutical Company Information
- 6.8.2 Guangxi Xiancaotang Pharmaceutical Business Overview
- 6.8.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.8.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Portfolio
- 6.8.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
- 6.9 Guangxi Xiancaotang
- 6.9.1 Guangxi Xiancaotang Company Information
- 6.9.2 Guangxi Xiancaotang Business Overview
- 6.9.3 Guangxi Xiancaotang Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.9.4 Guangxi Xiancaotang Artemisinin Derivatives Product Portfolio
- 6.9.5 Guangxi Xiancaotang Recent Developments
- 6.10 Novanat Bioresource
- 6.10.1 Novanat Bioresource Company Information
- 6.10.2 Novanat Bioresource Business Overview
- 6.10.3 Novanat Bioresource Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.10.4 Novanat Bioresource Artemisinin Derivatives Product Portfolio
- 6.10.5 Novanat Bioresource Recent Developments
- 6.11 KPC Pharmaceuticals
- 6.11.1 KPC Pharmaceuticals Company Information
- 6.11.2 KPC Pharmaceuticals Business Overview
- 6.11.3 KPC Pharmaceuticals Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.11.4 KPC Pharmaceuticals Artemisinin Derivatives Product Portfolio
- 6.11.5 KPC Pharmaceuticals Recent Developments
- 6.12 Botanical Extracts EPZ Ltd
- 6.12.1 Botanical Extracts EPZ Ltd Company Information
- 6.12.2 Botanical Extracts EPZ Ltd Business Overview
- 6.12.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.12.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Portfolio
- 6.12.5 Botanical Extracts EPZ Ltd Recent Developments
- 6.13 ArtemiFlow
- 6.13.1 ArtemiFlow Company Information
- 6.13.2 ArtemiFlow Business Overview
- 6.13.3 ArtemiFlow Artemisinin Derivatives Production, Value and Gross Margin (2021-2026)
- 6.13.4 ArtemiFlow Artemisinin Derivatives Product Portfolio
- 6.13.5 ArtemiFlow Recent Developments
7 Global Artemisinin Derivatives Production by Region
- 7.1 Global Artemisinin Derivatives Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Artemisinin Derivatives Production by Region (2021-2032)
- 7.2.1 Global Artemisinin Derivatives Production by Region (2021-2026)
- 7.2.2 Global Artemisinin Derivatives Production Forecast by Region (2027-2032)
- 7.3 Global Artemisinin Derivatives Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Artemisinin Derivatives Production Value by Region (2021-2032)
- 7.4.1 Global Artemisinin Derivatives Production Value by Region (2021-2026)
- 7.4.2 Global Artemisinin Derivatives Production Value by Region (2027-2032)
- 7.5 Global Artemisinin Derivatives Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Artemisinin Derivatives Production Value (2021-2032)
- 7.6.2 Europe Artemisinin Derivatives Production Value (2021-2032)
- 7.6.3 Asia-Pacific Artemisinin Derivatives Production Value (2021-2032)
- 7.6.4 South America Artemisinin Derivatives Production Value (2021-2032)
- 7.6.5 Middle East & Africa Artemisinin Derivatives Production Value (2021-2032)
8 Global Artemisinin Derivatives Consumption by Region
- 8.1 Global Artemisinin Derivatives Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Artemisinin Derivatives Consumption by Region (2021-2032)
- 8.2.1 Global Artemisinin Derivatives Consumption by Region (2021-2026)
- 8.2.2 Global Artemisinin Derivatives Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Artemisinin Derivatives Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Artemisinin Derivatives Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Artemisinin Derivatives Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Artemisinin Derivatives Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Artemisinin Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Artemisinin Derivatives Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Artemisinin Derivatives Value Chain Analysis
- 9.1.1 Artemisinin Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artemisinin Derivatives Production Mode & Process
- 9.2 Artemisinin Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemisinin Derivatives Distributors
- 9.2.3 Artemisinin Derivatives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst